Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
A Randomized, Controlled, Open Label Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
Status: Enrolling
Updated:  12/31/1969
Dallas Veterans Affairs Medical Center
348
mi
from
Dallas, TX
A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
A Randomized, Controlled, Open Label Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
Status: Enrolling
Updated: 12/31/1969
Dallas Veterans Affairs Medical Center
348
mi
from
Dallas, TX
Click here to add this to my saved trials
A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
A Randomized, Controlled, Open Label Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
349
mi
from
Dallas, TX
A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
A Randomized, Controlled, Open Label Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center - Princeton
682
mi
from
Birmingham, AL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center - Princeton
682
mi
from
Birmingham, AL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
University of Alabama Hospital
676
mi
from
Birmingham, AL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
University of Alabama Hospital
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Thomas Hospital
756
mi
from
Fairhope, AL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Thomas Hospital
756
mi
from
Fairhope, AL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center South
754
mi
from
Montgomery, AL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center South
754
mi
from
Montgomery, AL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Chandler Regional Medical Center
840
mi
from
Gilbert, AZ
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Chandler Regional Medical Center
840
mi
from
Gilbert, AZ
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Banner Heart Hospital
836
mi
from
Mesa, AZ
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Banner Heart Hospital
836
mi
from
Mesa, AZ
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Banner Good Samaritan Medical Center
851
mi
from
Phoenix, AZ
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Banner Good Samaritan Medical Center
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Scottsdale Healthcare
835
mi
from
Scottsdale, AZ
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Scottsdale Healthcare
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Arkansas Heart Hospital
365
mi
from
Little Rock, AR
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Arkansas Heart Hospital
365
mi
from
Little Rock, AR
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
John Muir Medical Center - Concord Campus
1316
mi
from
Concord, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
John Muir Medical Center - Concord Campus
1316
mi
from
Concord, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Washington Hospital
1317
mi
from
Fremont, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Washington Hospital
1317
mi
from
Fremont, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
1145
mi
from
La Jolla, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
1145
mi
from
La Jolla, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Scripps Memorial Hospital
1145
mi
from
La Jolla, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Scripps Memorial Hospital
1145
mi
from
La Jolla, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital
1169
mi
from
Los Angeles, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital
1169
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Sutter Central Valley Hospitals dba Memorial Medical Center
1282
mi
from
Modesto, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Sutter Central Valley Hospitals dba Memorial Medical Center
1282
mi
from
Modesto, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Mercy General Hospital
1280
mi
from
Sacramento, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Mercy General Hospital
1280
mi
from
Sacramento, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
UC Davis Medical Center
1283
mi
from
Sacramento, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
UC Davis Medical Center
1283
mi
from
Sacramento, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Sharp Memorial Hospital
1139
mi
from
San Diego, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial Hospital
1139
mi
from
San Diego, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Santa Barbara Cottage Hospital
1242
mi
from
Santa Barbara, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Santa Barbara Cottage Hospital
1242
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Stanford Hospital and Clinics
1329
mi
from
Stanford, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Clinics
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Little Company Of Mary Hospital
1179
mi
from
Torrance, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Little Company Of Mary Hospital
1179
mi
from
Torrance, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Torrance Memorial Medical Center
1179
mi
from
Torrance, CA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Torrance Memorial Medical Center
1179
mi
from
Torrance, CA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital
384
mi
from
Colorado Springs, CO
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital
384
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Medical Center of the Rockies
429
mi
from
Fort Collins, CO
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Medical Center of the Rockies
429
mi
from
Fort Collins, CO
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
1344
mi
from
New Haven, CT
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Medical Center
1311
mi
from
Stamford, CT
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Medical Center
1311
mi
from
Stamford, CT
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Christiana Care Health Services, Inc
1195
mi
from
Newark, DE
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Christiana Care Health Services, Inc
1195
mi
from
Newark, DE
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Brandon Regional Hospital
1123
mi
from
Brandon, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Brandon Regional Hospital
1123
mi
from
Brandon, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Morton Plant Hospital
1102
mi
from
Clearwater, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
1102
mi
from
Clearwater, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Holy Cross Hospital
1307
mi
from
Fort Lauderdale, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Holy Cross Hospital
1307
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Memorial Regional Hospital
1309
mi
from
Hollywood, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Memorial Regional Hospital
1309
mi
from
Hollywood, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Medical Center
1055
mi
from
Jacksonville, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Medical Center
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center - Downtown
1056
mi
from
Jacksonville, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center - Downtown
1056
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
University of Florida UF Health
1052
mi
from
Jacksonville, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
University of Florida UF Health
1052
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
University of Miami Hospital
1320
mi
from
Miami, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
University of Miami Hospital
1320
mi
from
Miami, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Baptist Hospital of Miami
1321
mi
from
Miami, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital of Miami
1321
mi
from
Miami, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Munroe Regional Medical Center
1080
mi
from
Ocala, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Munroe Regional Medical Center
1080
mi
from
Ocala, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Florida Hospital
1142
mi
from
Orlando, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
1142
mi
from
Orlando, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Palm Beach Gardens Medical Center
1276
mi
from
Palm Beach Gardens, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Palm Beach Gardens Medical Center
1276
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Bay County Health Systems
870
mi
from
Panama City, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Bay County Health Systems
870
mi
from
Panama City, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Baptist Hospital
789
mi
from
Pensacola, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital
789
mi
from
Pensacola, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Tallahassee Memorial Hospital
925
mi
from
Tallahassee, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Tallahassee Memorial Hospital
925
mi
from
Tallahassee, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
1117
mi
from
Tampa, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Florida Hospital - Pepin Heart Institute
1117
mi
from
Tampa, FL
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Florida Hospital - Pepin Heart Institute
1117
mi
from
Tampa, FL
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Emory Hospital-Midtown
800
mi
from
Atlanta, GA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Emory Hospital-Midtown
800
mi
from
Atlanta, GA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Piedmont Hospital
800
mi
from
Atlanta, GA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Piedmont Hospital
800
mi
from
Atlanta, GA
Click here to add this to my saved trials
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
803
mi
from
Atlanta, GA
ABSORB III Randomized Controlled Trial (RCT)
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
803
mi
from
Atlanta, GA
Click here to add this to my saved trials